Pharmacology
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
This section essentially covers all aspects of pharmacology, including pharmacodynamics, pharmacokinetics and toxicology. Research papers should provide rigorous quantitative analyses and/or new insights on intermolecular reactions of drugs with chemical constituents of cells, tissues, organs or organ systems.
It publishes high quality original research and authoritative reviews, commentary and letters to the editor.
Keywords
- Behavioral pharmacology
- Cancer pharmacology
- Cardiovascular pharmacology
- Chronopharmacology
- Clinical pharmacology
- Immunopharmacology
- Molecular and biochemical pharmacology
- Neuropharmacology
- Pharmacoepidemiology
- Pharmacogenetics/pharmacogenomics
- Pharmacokinetics
- Systems pharmacology
- Toxicology
- Translational pharmacology/medicine
- Safety pharmacology
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Pharmacotherapy for Macular Diseases (Deadline: 5 March 2021)
- Clinical and Forensic Toxicology: The Latest Updates (Deadline: 22 March 2021)
- The Prediction of Pharmacokinetics/Pharmacodynamics Using In-Silico Modeling (Deadline: 30 March 2021)
- TP53 Tumor Suppressor in Gynecologic Cancers (Deadline: 31 March 2021)
- Affective Disorders Psychopharmacology (Deadline: 31 March 2021)
- The Pharmacogenomics of Mood Stabilizers (Deadline: 31 March 2021)
- Developmental Origins and Emerging Therapeutic Opportunities for Uterine Fibroids (Deadline: 31 March 2021)
- Pharmacology of Neuropeptide S Receptor (Deadline: 31 March 2021)
- Neuroendocrine Neoplasms and Endocrine Glands Tumors: Pharmacological and Clinical Aspects (Deadline: 31 March 2021)
- Stress, Neurotransmitters and Neurodegeneration (Deadline: 1 April 2021)
- Molecular Mechanism of Inflammasome Activation: Implications in Physiological and Pathological Conditions (Deadline: 1 April 2021)
- Potential Molecular Targets and Therapeutics in Triple-Negative Breast Cancer (Deadline: 9 April 2021)
- Repurposing Drug Strategies for CNS Disorders (Deadline: 19 April 2021)
- Superoxide Dismutase Activity in Different Health Conditions (Deadline: 30 April 2021)
- Molecular Targeting of Glioblastoma: Drug Discovery and Therapies (Deadline: 30 April 2021)
- Pharmacokinetics and Pharmacodynamics of Psychoactive Substances: Clinical and Forensic Aspects (Deadline: 30 April 2021)
- Safety and Benefits of Modern Hormonal Contraceptives (Deadline: 30 April 2021)
- Molecular and Cellular Targets of Old and New Atypical Antipsychotics (Deadline: 15 May 2021)
- Influence of Chemicals on the Cytoskeleton: Modulation of Stem Cell Dynamics (Deadline: 30 May 2021)
- Pharmaceutical and Cellular Strategies to Treat GVHD (Deadline: 31 May 2021)
- Searching for New Therapeutic Targets with Anti-Obesity Potential (Deadline: 31 May 2021)
- PI3K: From Basic Science to Clinical Translation (Deadline: 31 May 2021)
- Role of DNA Damage and Repair in Aging (Deadline: 1 June 2021)
- Advances in Ocular Pharmacology (Deadline: 7 June 2021)
- Evaluation of the Antitumor Mechanism of Armed Antibodies (Deadline: 15 June 2021)
- Novel Therapeutic Targets in Cancer (Deadline: 21 June 2021)
- Statins Use and Cancer (Deadline: 30 June 2021)
- Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals (Deadline: 30 June 2021)
- Targeting Proline Metabolic Pathway for Regulation of Apoptosis/Autophagy in Cancer (Deadline: 30 June 2021)
- Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets (Deadline: 30 June 2021)
- Lung Injury and Repair (Deadline: 30 June 2021)
- Ion Channels: Current Pharmacological Challenges (Deadline: 15 July 2021)
- The Regulation of JAKs in Health and in Disease (Deadline: 30 July 2021)
- Molecular Pharmacology of 5-HT Receptors (Deadline: 30 July 2021)
- Drug-induced Ototoxicity: Mechanisms and Otoprotective Strategies (Deadline: 31 July 2021)
- Precision Medicine in Oncology: Controlling the Pharmacokinetics Variability (Deadline: 1 August 2021)
- Anti-cancer Drugs Induced Toxicity and Interventions 2021 (Deadline: 16 August 2021)
- Advances in the Management of Diabetic Nephropathy (Deadline: 27 August 2021)
- Potential Carcinogenicity of Drugs (Deadline: 31 August 2021)
- Mechanisms of Antibiotic Action and Resistance (Deadline: 31 August 2021)
- New Pharmacologic Approaches to Study and Intervene in Epithelial to Mesenchymal Transition (EMT) and Fibrosis (Deadline: 30 September 2021)
- TRPA1 Receptor as a Potential Therapeutic Target in Pain, Inflammation and Neurodegeneration (Deadline: 30 September 2021)
Topical Collection
Following topical collection within this section is currently open for submissions:
